Literature DB >> 17706780

Mechanisms of action of deep brain stimulation(DBS) .

Erwin B Montgomery1, John T Gale.   

Abstract

Deep brain stimulation (DBS) is remarkably effective for a range of neurological and psychiatric disorders that have failed pharmacological and cell transplant therapies. Clinical investigations are underway for a variety of other conditions. Yet, the therapeutic mechanisms of action are unknown. In addition, DBS research demonstrates the need to re-consider many hypotheses regarding basal ganglia physiology and pathophysiology such as the notion that increased activity in the globus pallidus internal segment is causal to Parkinson's disease symptoms. Studies reveal a variety of apparently discrepant results. At the least, it is unclear which DBS effects are therapeutically effective. This systematic review attempts to organize current DBS research into a series of unifying themes or issues such as whether the therapeutic effects are local or systems-wide or whether the effects are related to inhibition or excitation. A number of alternative hypotheses are offered for consideration including suppression of abnormal activity, striping basal ganglia output of misinformation, reduction of abnormal stochastic resonance effects due to increased noise in the disease state, and reinforcement of dynamic modulation of neuronal activity by resonance effects.

Entities:  

Mesh:

Year:  2007        PMID: 17706780     DOI: 10.1016/j.neubiorev.2007.06.003

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  107 in total

Review 1.  Linking molecules to mood: new insight into the biology of depression.

Authors:  Vaishnav Krishnan; Eric J Nestler
Journal:  Am J Psychiatry       Date:  2010-09-15       Impact factor: 18.112

2.  Sustained cortical and subcortical neuromodulation induced by electrical tongue stimulation.

Authors:  Joseph C Wildenberg; Mitchell E Tyler; Yuri P Danilov; Kurt A Kaczmarek; Mary E Meyerand
Journal:  Brain Imaging Behav       Date:  2010-12       Impact factor: 3.978

3.  Short latency activation of cortex during clinically effective subthalamic deep brain stimulation for Parkinson's disease.

Authors:  Harrison C Walker; He Huang; Christopher L Gonzalez; James E Bryant; Jeffrey Killen; Gary R Cutter; Robert C Knowlton; Erwin B Montgomery; Bart L Guthrie; Ray L Watts
Journal:  Mov Disord       Date:  2012-05-30       Impact factor: 10.338

4.  Effects of DBS on auditory and somatosensory processing in Parkinson's disease.

Authors:  Katja Airaksinen; Jyrki P Mäkelä; Samu Taulu; Antti Ahonen; Jussi Nurminen; Alfons Schnitzler; Eero Pekkonen
Journal:  Hum Brain Mapp       Date:  2010-07-19       Impact factor: 5.038

5.  Deep brain stimulation in Parkinson's disease.

Authors:  S J Groiss; L Wojtecki; M Südmeyer; A Schnitzler
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

6.  Modeling the effects of Deep Brain Stimulation on sensorimotor cortex in normal and MPTP conditions.

Authors:  S Santaniello; J T Gale; E B Montgomery; S V Sarma
Journal:  Annu Int Conf IEEE Eng Med Biol Soc       Date:  2010

7.  Deep brain stimulation of the globus pallidus internus in the parkinsonian primate: local entrainment and suppression of low-frequency oscillations.

Authors:  Kevin W McCairn; Robert S Turner
Journal:  J Neurophysiol       Date:  2009-01-21       Impact factor: 2.714

Review 8.  Deep brain stimulation for the treatment of addiction: basic and clinical studies and potential mechanisms of action.

Authors:  R Christopher Pierce; Fair M Vassoler
Journal:  Psychopharmacology (Berl)       Date:  2013-08-02       Impact factor: 4.530

9.  Reciprocal interactions between the human thalamus and periaqueductal gray may be important for pain perception.

Authors:  Dali Wu; Shouyan Wang; John F Stein; Tipu Z Aziz; Alexander L Green
Journal:  Exp Brain Res       Date:  2013-11-12       Impact factor: 1.972

10.  Deep brain stimulation does not silence neurons in subthalamic nucleus in Parkinson's patients.

Authors:  Jonathan D Carlson; Daniel R Cleary; Justin S Cetas; Mary M Heinricher; Kim J Burchiel
Journal:  J Neurophysiol       Date:  2009-12-02       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.